Cargando…
MB109 as bioactive human bone morphogenetic protein-9 refolded and purified from E. coli inclusion bodies
BACKGROUND: The development of chemical refolding of transforming growth factor-beta (TGF-β) superfamily ligands has been instrumental to produce the recombinant proteins for biochemical studies and exploring the potential of protein therapeutics. The osteogenic human bone morphogenetic protein-2 (h...
Autores principales: | Kuo, Mario Meng-Chiang, Nguyen, Phuong Hong, Jeon, Yun-Hui, Kim, Subin, Yoon, So-Mi, Choe, Senyon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936849/ https://www.ncbi.nlm.nih.gov/pubmed/24559319 http://dx.doi.org/10.1186/1475-2859-13-29 |
Ejemplares similares
-
Inclusion Body Expression and Refolding of Recombinant Bone Morphogenetic Protein-2
por: Nasrabadi, Davood, et al.
Publicado: (2018) -
Refolding and characterization of two G protein-coupled receptors purified from E. coli inclusion bodies
por: Heim, Bastian, et al.
Publicado: (2021) -
Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population
por: Jung, Jae Woo, et al.
Publicado: (2016) -
Refolding of bioactive human epidermal growth factor from E. coli BL21(DE3) inclusion bodies & evaluations on its in vitro & in vivo bioactivity
por: Maksum, Iman Permana, et al.
Publicado: (2022) -
Chemical Assistance in Refolding of Bacterial Inclusion Bodies
por: Alibolandi, Mona, et al.
Publicado: (2011)